Clinical Trial Update: A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating the safety and efficacy of APG-157 in oral and oropharyngeal dysplasia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Carcinoma in Situ
• Oral Cavity Dysplasia
• Oropharyngeal Dysplasia

Drugs mentioned

• APG-157

Snippet

Sponsor: Elizabeth J Franzmann | Conditions: Oropharyngeal Dysplasia, Oral Cavity Dysplasia | Phase 2 | Status: RECRUITING